New China Life Stock EBITDA
NCL Stock | EUR 2.88 0.00 0.00% |
New China Life fundamentals help investors to digest information that contributes to New China's financial success or failures. It also enables traders to predict the movement of New Stock. The fundamental analysis module provides a way to measure New China's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to New China stock.
New |
New China Life Company EBITDA Analysis
New China's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition |
According to the company disclosure, New China Life reported earnings before interest,tax, depreciation and amortization of 0.0. This indicator is about the same for the Other average (which is currently at 0.0) sector and about the same as Other (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
New EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses New China's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of New China could also be used in its relative valuation, which is a method of valuing New China by comparing valuation metrics of similar companies.New China is currently under evaluation in ebitda category among its peers.
New Fundamentals
Current Valuation | 10.38 B | |||
Price To Book | 0.50 X | |||
Price To Sales | 0.24 X | |||
Revenue | 222 B | |||
Net Income | 14.95 B | |||
Total Debt | 10 B | |||
Cash Flow From Operations | 73.85 B | |||
Price To Earnings To Growth | 1.01 X | |||
Number Of Employees | 45 | |||
Market Capitalization | 13.89 B | |||
Total Asset | 1.13 T | |||
Z Score | 0.6 | |||
Annual Yield | 0.27 % | |||
Net Asset | 1.13 T | |||
Last Dividend Paid | 0.88 |
About New China Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze New China Life's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of New China using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of New China Life based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in New Stock
New China financial ratios help investors to determine whether New Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in New with respect to the benefits of owning New China security.